ATI-1503

N/A

Report date: 2025/01/26 17:35:14
NME

Base Information

Drug NameATI-1503
Drug Alias NameATI-1503
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of Action30S ribosomal subunit modulators
Targets30S ribosomal subunit
Therapy Area/IndicationsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAppili Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAppili Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGram-Negative Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A